Navigation Links
Icahn Nominates 4 to Genzyme Slate
Date:2/23/2010

ntities affiliated with Carl C. Icahn, including Icahn Partners, Icahn Master, Icahn Master II and Icahn Master III.  Icahn Partners, Icahn Master, Icahn Master II and Icahn Master III are private investment funds.  Dr. Denner has served in this position since August 2006.  From April 2005 to May 2006, Dr. Denner served as a portfolio manager specializing in healthcare investments for Viking Global Investors.  Previously, he served in a variety of roles at Morgan Stanley, beginning in 1996, including as portfolio manager of healthcare and biotechnology mutual funds.  Dr. Denner was the chairman of the Executive Committee of the Board of Directors of ImClone Systems Incorporated, a publicly traded biopharmaceutical company, and a director of ImClone Systems Incorporated from April 2006 until the company was purchased in December 2008.  He served on the Board of Adventrx Pharmaceuticals Inc., a publicly traded biopharmaceutical company from October 2006 to October 2009. In addition, Dr. Denner has served as a director of Biogen Idec Pharmaceuticals, a publicly traded biopharmaceutical company from June, 2009 until the present, as a director of Amylin Pharmaceuticals, Inc., a publicly traded biopharmaceutical company since June 2009, as a director of Enzon Pharmaceuticals, a publicly traded biopharmaceutical company from May 2009 until the present, and as Chairman of the Board of Directors of Enzon Pharmaceuticals from July, 2009 until the present.  Dr. Denner received his S.B. degree from the Massachusetts Institute of Technology and his M.S., M.Phil., and Ph.D. degrees from Yale University
'/>"/>
SOURCE Carl Icahn
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Icahn Indicates That Biogen Board Refuses To Close Polls
2. Amylin Issues Statement in Response to Carl Icahn
3. Icahn Asks Amylin to Allow Discussions With Eastbourne
4. Icahn Responds to Cornelius
5. Icahn Confirms Intention to Nominate Three Directors at Biogen
6. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
7. Genzyme Reports Strong Second-Quarter Growth
8. Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases
9. Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise
10. Genzyme Files Applications for Approval of Mozobil in the United States and Europe
11. Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled a ... EST (11am PST), “Natural Language Processing: Converting Raw Data ... can turn raw, heterogeneous data into actionable knowledge to ... webinar will last approximately one hour. , Synopsis: Big ...
(Date:1/14/2014)... 2014  3D Communications, a leading provider of strategic communications services to ... events in the United States and ... Cox , JD, is returning to the firm,s Washington, ... 3D after more than two years of service as Associate Commissioner ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Estate Equities, Inc. (NYSE: ARE ), Landlord of ... , today provided an update highlighting recent accomplishments. , ... Pfizer Inc. at the Alexandria Center for Science and ... Pfizer Inc. entered into a 15-year lease for approximately ...
... Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 8th ... a.m. Pacific Time. , The conference is being held October 28-29, 2009, at ... with slides and available for replay afterwards. The webcast can be accessed at ... ...
... Ind., Oct. 28 Zimmer Holdings, Inc. (NYSE: ... Grants Association LLC (OMeGA) has chosen its 2009 grant ... administrator for graduate medical education to which Zimmer committed ... 2009-2010 academic year. , OMeGA received more than 250 ...
Cached Biology Technology:Alexandria Real Estate Equities, Inc. Provides Update 2Alexandria Real Estate Equities, Inc. Provides Update 3Alexandria Real Estate Equities, Inc. Provides Update 4Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 2Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 3Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 4
(Date:4/24/2014)... Researchers from North Carolina State University and the University ... new ultrasound device that could help identify arterial plaque ... causing heart attack or stroke. , At issue is ... age. Some types of plaque are deemed "vulnerable," meaning ... artery wall and cause heart attack or stroke. , ...
(Date:4/24/2014)... of clear liquid can bend light, acting as a ... developed a new process to create inexpensive high quality ... , Because they,re so inexpensive, the lenses can ... to detect diseases in the field, scientific research in ... in classrooms. , "What I,m really excited about ...
(Date:4/23/2014)... chronic inflammatory disorders among people of lower socioeconomic status ... to the microbes that thrive in rural environments, according ... in the journal Clinical & Experimental Immunology , ... less access to green spaces may be more apt ... system dysfunction. , When our immune systems are working ...
Breaking Biology News(10 mins):New ultrasound device may add in detecting risk for heart attack, stroke 2Bake your own droplet lens 2Bake your own droplet lens 3Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3
... to over hunting in the 19th century, wild elk ... of the Ontario elk restoration program. According to a ... issue of Restoration Ecology, 460 elk were brought from ... and 2001. , "The Ontario elk restoration program has ...
... Researchers at the University of Illinois at Urbana-Champaign ... optical microscopy that can produce crisp, three-dimensional images ... Aperture Microscopy, ISAM can do for optical microscopy ... resonance, and what computed tomography did for X-ray ...
... gene has been discovered by scientists at the Lundberg Laboratory ... Sahlgrenska Academy in Sweden. The researchers found that women with ... higher risk of contracting breast cancer than expected. , ... for new hereditary breast cancer genes, but thus far few ...
Cached Biology News:Novel computed imaging technique uses blurry images to enhance view 2New hereditary breast cancer gene discovered 2
... Kit uses a simplified procedure and streamlines ... The kit is based on the three ... and sodium bisulfite where cytosine is converted ... innovative in-column desulphonation reaction eliminates several precipitation ...
... The DIGIVIEW line of digital x-ray ... radiation imaging device complete with 12 to ... area consists of a photodiode array sensor ... All models are available in low x-ray ...
Metamine is an autonomous data mining tool that extends the capabilities of conventional research teams. It is a proactive agent that searches for significant results buried within the GeNet data rep...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selecitivty and potential CNS-Side Effect liabilities of compo...
Biology Products: